Skip to Content

Torsemide Injection

Last Updated: December 29, 2017
Status: Current

Torsemide Injection

Products Affected - Description
  • Torsemide solution for injection, American Regent
    10 mg/mL, 2 mL vial, 10 count (NDC 00517-0770-10)

10 mg/mL, 5 mL vial, 10 count (NDC 00517-0771-10)
Reason for the Shortage
    • Roche discontinued Demadex injection for business reasons. Demadex tablets are not affected by this shortage.
    • American Regent has torsemide on shortage due to manufacturing delays.
Available Products
  • There are no presentations available.

Estimated Resupply Dates

  • American Regent has torsemide injection on long-term back order and the company cannot estimate a release date.

Updated

December 29, November 11, September 6, June 25, May 2, January 30, 2017; November 11, August 5, May 9, February 29, 2016; December 8, September 10, June 15, March 23, January 16, 2015; October 21, July 29, April 22, January 21, 2014; July 16, May 9, April 4, January 14, 2013; November 20, September 19, July 25, May 23, April 11, March 29, 2012, University of Utah, Drug Information Service. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide